13F filing recap · Q4 2022
What did Brave Warrior Advisors buy in Q4 2022?
Reported stock-position changes between this filing and the previous one.
Stock value
$3.17B
Positions
26
Estimated turnover
16.9%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.